To generate a vaccine against SARS-CoV-2 using a novel polymer for mRNA protection.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Ronald LevyResearch Location
United States of AmericaLead Research Institution
Stanford UniversityResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
To generate a vaccine against SARS-CoV-2 using a novel polymer for mRNA protection.